1/ Did I Miss the Value Turn? (Arnott, Kalesnik, Wu)
"Value stocks remain priced at very attractive valuations across most regional markets—discounts in the bottom half of the cheapest decile. We may wait decades for another opportunity of this scale."
2/ "Value posted the worst drawdown in its history over the years 2017–2020.
"Value’s pre-pandemic drawdown in developed markets was slightly shorter than in the U.S. but was even deeper at 19%. In emerging markets, value continued to work until late 2018."
3/ "From Jan 2007 to Sept 2020 in the U.S., relative valuation moved from the most expensive quartile to the cheapest percentile; this explains more than 100% of value’s underperformance.
"Net of this downward revaluation, value would have beat growth by a respectable margin."
4/ "During the two recessions spurred by the bursting of an asset bubble, value markedly outpaced growth during the associated bear market. In recessions triggered by shocks to economic fundamentals and unassociated with a bubble, value typically performed in line with growth.
5/ "Value’s outperformance during recoveries should not be surprising, because as recessions ease, the risk of bankruptcy—typically afflicting value stocks with their slower growth, thinner profit margins, and weaker prospects—recedes."
6/ "The value rebound that began in Sept. 2020 was consistent with historical precedent. By late summer of 2020, value was priced at extreme discounts—by some measures (e.g., P/B & P/S), the deepest ever.
"Through mid-May 2021, value was rebounding across all regional markets."
7/ "The discount for value no longer falls in the 100th percentile, yet it still displays impressively cheap discounts across all regions but one. In most markets, the discounts are not only in the cheapest decile in history; they are in the bottom half of the cheapest decile."
8/ "Today, $13 trillion of bonds worldwide are priced at a negative yield to maturity. Other assets—including the most expensive tech stocks—are also priced to generate negative real returns, even if the companies are able to achieve the lofty growth the market currently expects.
9/ "Yet global markets are hardly devoid of opportunity. International and EM stocks are far cheaper than US stocks. The biggest outliers in long-term expected real returns are value stocks.
10/ "In the U.K., 71% of the population had at least one dose of the vaccine and 63% were fully vaccinated as of August 2021. 91% of adults in England & 94% in London tested positive for antibodies, which means a significant portion of the
unvaccinated had Covid and recovered.
11/ "In that country, the estimated ratio of deaths to _known_ Covid cases is 0.2%, not too different from the same ratio for seasonal flu. As more people become vaccinated or acquire natural immunity, the world’s prospects for living with the endemic presence of Covid are good.
12/ "As the pandemic wanes, many of the tech companies that greatly benefitted from the lockdowns and work-from-home will likely cede some of those benefits. While some pandemic-era behavior changes will prove lasting, we believe most people will revert partway to past habits.
13/ "Many of the economic and behavioral trends that supported these high-flying companies are likely to reverse course. The high valuations and high market concentrations typical of these (mainly tech) stocks create further risks to investors who hold them.
14/ "Cisco has had double-digit growth in sales, profits, & book value since it was briefly the largest-cap stock in the world, yet its share price is still down from its 2000 peak price.
“Some of these share prices are not only discounting the future, but also the hereafter.”
15/ "The energy sector has ridden a wave of bankruptcies over the lockdown period. Industry survivors should be able to operate with richer margins. Further, OPEC+ agreed during the pandemic to tighten control on oil production to stabilize prices as energy demand plummeted.
16/ "The combination of potential underinvestment from bankruptcies and tighter supplies led to short-term oil shortages, with oil prices reaching higher levels. Given the cheap valuations of some major energy companies, these shocks could be great news for value investors."
"Even unlikely events must eventually come to pass. Therefore, anyone who accepts small risks of losing everything eventually _will_ lose everything. The compound return rate is acutely sensitive to fat tails."
2/ "Looked at another way, a coin toss is physics. An event is random only when no one cares to predict it.
"Thorp discovered that he was able to guess approximately where the roulette ball would land: The wheel was slightly tilted. This made the ball favor the downhill side."
3/ "Money management is the tricky & all-important issue of how to extract the greatest profit from a favorable opportunity. You can be the world’s greatest poker player, but if you can’t manage your money, you’ll end up broke. Sadly, almost everyone goes broke in the long run."
Money gives you freedom, which can then be allocated toward one or more goals:
* not have a job any more
* simplify your business / align it with your values
* help others
* accept negative expected returns (big house, nice car)
(The fourth one may be more stuffy than it seems!)
2/ "College admissions is not about you; it’s about the college. It’s not about being “worthy” per se; it’s more about fitting into a college’s agenda, whatever that might be.
In a given year, that might mean more full payers, humanities majors, and students from the Dakotas.
3/ "Sometimes the goals are narrower: a pitcher for the baseball team, a goalie for the soccer team, or an oboist for the orchestra. Many colleges give special consideration to applicants w/ deep, lasting connections to the school (e.g., children of alumni & employees)." (p. 9)
1/ Investor Demand for Leverage: Evidence from Equity Closed-End Funds (Dam, Davies, Moon)
"We document a strong negative relation between equity CEF fund leverage and associated discounts, indicating that investors pay a relative premium for leverage."
2/ "Each year, we segment funds into two categories: pure equity and mixed-allocation funds. These categories are primarily based on Bloomberg classifications. We manually classify the funds that Bloomberg does not cover. The vast majority of our funds are purely equity-focused."
3/ "To prevent survivorship bias, we do not require funds to have the data from Bloomberg.
"When we use a binary indicator for whether a fund is levered, we set it to zero for funds not covered by Bloomberg. This is conservative (biasing in the direction of finding no result)."
"In contrast to the widely held belief, mispricing associated with the 11 L/S anomalies underlying our composite ranking measure appears to be at least as prevalent in developed markets as in emerging markets."
2/ Caveats: "Emerging markets appear to be comparatively under-researched. This likely has led to a better understanding of which factors truly have predictive power in more mature markets, and the Stambaugh, Yu, and Yuan mispricing score could be partly based on such variables."
3/ "Ranks are standardized to be uniformly distributed over the interval (0,1] in each country-month. A stock's composite rank is computed as the arithmetic average of its anomaly ranks.
"I rely on yearly (not quarterly) accounting data due to limited data availability."
"The most important aspect of cancer progression is the growth pathways of the body, which are also the nutrient-sensing pathways. While there is more to discover, this new paradigm represents a huge leap forward." (p.311)
2/ "In medical research, opinions that dissent from the specified narrative are not welcome.
"John Maynard Keynes is quoted as having said, “The difficulty lies not so much in developing new ideas as in escaping from old ones.” " (p. 3)
3/ "From 1990 to 2002, 68% of the FDA approvals were for cancer drugs that did not necessarily improve life expectancy.
"The most common reason for approval is called the “partial tumor response rate:” the drugs were shown to shrink the primary tumor in volume by over 50%.